Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, Respiratory viral infections research, and COVID-19 Clinical Research Studies.
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
Limited extent and consequences of pancreatic SARS-CoV-2 infection
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine**
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection